Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1212-1225
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1212
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1212
Diagnostic criteria | Venous plasma glucose levels (mmol/L) |
Diabetic symptoms and random blood glucose | ≥ 11.1 mmol/L |
Fasting plasma glucose | ≥ 7.0 mmol/L |
Plasma glucose 2 h after oral glucose tolerance test | ≥ 11.1 mmol/L |
- Citation: Li JJ, Sa RL, Zhang Y, Yan ZL. Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C. World J Diabetes 2024; 15(6): 1212-1225
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1212.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1212